Sage Therapeutics to Present at the Goldman Sachs 37th Annual Global Healthcare Conference

Sage Therapeutics Announces Completion of Enrollment for Phase 2 Proof-of-Concept Trial of SAGE-547 in Severe Postpartum Depression

Jounce Therapeutics Appoints Barbara G. Duncan to its Board of Directors

CytomX to Present at the Jefferies 2016 Healthcare Conference

Editas Medicine to Present at Upcoming June Investor Conferences